Brochure

Plug Into The Future Of Bispecific Antibodies

Source: Lonza
GettyImages-1133973940-immunoglobulin-cell-culture-antibody

bYlok® is changing the way bispecific antibodies are designed. Achieving the correct heterodimerization of light and heavy chains during bispecific production can be challenging, and whilst the knobs-into-holes technology solves heavy chain mispairing, bYlok® offers a solution to address HC-LC mispairing.

bYlok® technology delivers >95% correct HC-LC pairing efficiency. It works on the principle of being closer-to-nature by design, reducing the risk of any unwanted immunogenicity, whilst offering superior manufacturing efficiencies to ease bispecific production at scale.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online